Skandinaviska Enskilda Banken AB publ cut its position in Nu Skin Enterprises, Inc. (NYSE:NUS) by 30.8% during the 3rd quarter, HoldingsChannel reports. The firm owned 142,400 shares of the company’s stock after selling 63,400 shares during the quarter. Skandinaviska Enskilda Banken AB publ’s holdings in Nu Skin Enterprises were worth $11,737,000 at the end of the most recent reporting period.
A number of other hedge funds and other institutional investors have also recently bought and sold shares of NUS. BlackRock Inc. lifted its stake in Nu Skin Enterprises by 11.5% in the 2nd quarter. BlackRock Inc. now owns 6,143,407 shares of the company’s stock worth $480,352,000 after purchasing an additional 635,246 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. lifted its stake in Nu Skin Enterprises by 410.1% in the 3rd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 427,800 shares of the company’s stock worth $35,259,000 after purchasing an additional 343,935 shares in the last quarter. Renaissance Technologies LLC lifted its stake in Nu Skin Enterprises by 51.1% in the 2nd quarter. Renaissance Technologies LLC now owns 814,000 shares of the company’s stock worth $63,647,000 after purchasing an additional 275,200 shares in the last quarter. Assenagon Asset Management S.A. lifted its stake in Nu Skin Enterprises by 524.5% in the 3rd quarter. Assenagon Asset Management S.A. now owns 295,551 shares of the company’s stock worth $24,359,000 after purchasing an additional 248,222 shares in the last quarter. Finally, Acadian Asset Management LLC lifted its stake in Nu Skin Enterprises by 112.2% in the 2nd quarter. Acadian Asset Management LLC now owns 368,804 shares of the company’s stock worth $28,834,000 after purchasing an additional 194,990 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company’s stock.
NUS has been the topic of several recent analyst reports. Citigroup set a $88.00 target price on shares of Nu Skin Enterprises and gave the stock a “buy” rating in a research note on Thursday. Jefferies Financial Group reiterated a “buy” rating and issued a $92.00 target price on shares of Nu Skin Enterprises in a research note on Thursday. DA Davidson started coverage on shares of Nu Skin Enterprises in a report on Tuesday, October 9th. They issued a “buy” rating and a $92.00 price target on the stock. Zacks Investment Research raised shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating in a report on Monday, October 15th. Finally, Stifel Nicolaus raised shares of Nu Skin Enterprises from a “sell” rating to a “hold” rating and increased their price target for the stock from $57.00 to $70.00 in a report on Thursday, August 2nd. They noted that the move was a valuation call. One analyst has rated the stock with a sell rating, two have assigned a hold rating and five have given a buy rating to the company. The stock has an average rating of “Buy” and a consensus price target of $86.29.
In other news, General Counsel D Matthew Dorny sold 2,500 shares of the stock in a transaction on Tuesday, September 4th. The shares were sold at an average price of $79.90, for a total value of $199,750.00. Following the transaction, the general counsel now owns 33,871 shares of the company’s stock, valued at approximately $2,706,292.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. 5.20% of the stock is owned by corporate insiders.
Shares of NYSE:NUS opened at $65.02 on Friday. The firm has a market capitalization of $4.05 billion, a PE ratio of 20.13, a P/E/G ratio of 1.78 and a beta of 1.04. Nu Skin Enterprises, Inc. has a one year low of $60.60 and a one year high of $88.68. The company has a debt-to-equity ratio of 0.46, a quick ratio of 1.19 and a current ratio of 1.82.
Nu Skin Enterprises (NYSE:NUS) last issued its quarterly earnings results on Wednesday, November 7th. The company reported $0.94 EPS for the quarter, missing the Zacks’ consensus estimate of $0.96 by ($0.02). The company had revenue of $675.31 million during the quarter, compared to the consensus estimate of $664.99 million. Nu Skin Enterprises had a return on equity of 28.06% and a net margin of 5.93%. Nu Skin Enterprises’s quarterly revenue was up 19.8% on a year-over-year basis. During the same period in the previous year, the company earned $0.76 EPS. Research analysts expect that Nu Skin Enterprises, Inc. will post 3.52 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, December 12th. Stockholders of record on Friday, November 30th will be issued a $0.365 dividend. This represents a $1.46 dividend on an annualized basis and a dividend yield of 2.25%. The ex-dividend date is Thursday, November 29th. Nu Skin Enterprises’s payout ratio is 45.20%.
COPYRIGHT VIOLATION NOTICE: This piece was originally published by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international copyright & trademark laws. The correct version of this piece can be viewed at https://www.dispatchtribunal.com/2018/11/10/nu-skin-enterprises-inc-nus-holdings-cut-by-skandinaviska-enskilda-banken-ab-publ.html.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc develops and distributes anti-aging personal care products and nutritional supplements under the Nu Skin and Pharmanex category brands worldwide. It provides skin care systems and targeted treatment products, including ageLOC Me customized skin care systems, ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products, as well as a range of other cosmetic, personal care, and hair care products.
Featured Article: Are analyst ratings accurate?
Want to see what other hedge funds are holding NUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Nu Skin Enterprises, Inc. (NYSE:NUS).
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.